Organization · Venture Studio
Persephoni BioPartners
Persephoni BioPartners is a biotechnology venture studio based in the United States, focused on transforming early-stage scientific breakthroughs into therapeutics. It partners with innovators and academic institutions to build high-impact biotech companies.
Overview
What Persephoni BioPartners does
What Persephoni BioPartners is
Persephoni BioPartners is a biotechnology venture studio based in the United States, focused on transforming early-stage scientific breakthroughs into therapeutics. It partners with innovators and academic institutions to build high-impact biotech companies.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 29, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Persephoni BioPartners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Persephoni BioPartners as a funder
Investment thesis
Persephoni BioPartners focuses on transforming scientific breakthroughs into real-world therapeutics by partnering with innovators at the earliest stages. They seek biotech opportunities rooted in differentiated biology with a clear path to human health impact.
Focus narrative
Persephoni BioPartners invests in early-stage biotech companies that have the potential to impact human health through therapeutic, diagnostic, or platform-based innovations. They prioritize ventures with foundational, differentiated science supported by strong preclinical data and a clear path to clinical relevance, focusing on areas such as autoimmunity, oncology, and viral diseases.
Value beyond capital
Persephoni BioPartners adds value by providing hands-on support in company formation, operational execution, and capital access. They collaborate closely with founders to develop clinical strategies, enhance intellectual property, and facilitate partnerships, ensuring that portfolio companies are well-positioned for long-term growth.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+
- Sectors
- Biotech · Healthcare · Diagnostics
- Regions
- United States · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Notable portfolio companies include: LampRNA Therapeutics: Develops a lysosome-mediated RNA degrader platform to enhance the efficacy of RNA interfering therapies. Telos Therapeutics: A preclinical-stage biotech company creating exosome-based therapies for autoimmunity and oncology. InnoVira: Focuses on developing the first EBV-specific antiviral medication targeting conditions like multiple sclerosis and certain cancers. Monarch Therapeutics: Offers a catalog of modular adaptors for personalized therapy programs.
Capability profile
Persephoni BioPartners as a program host
Program thesis
Persephoni BioPartners is a biotechnology venture studio that partners with innovators at the earliest stages to transform scientific breakthroughs into real-world therapeutics.
Focus narrative
Persephoni BioPartners invests in early-stage biotech companies rooted in biology with the potential to impact human health through therapeutic, diagnostic, or platform-based innovations. The organization prioritizes ventures with robust intellectual property and scalable business models designed for long-term growth, focusing on areas such as autoimmunity, oncology, and viral diseases, particularly those associated with Epstein-Barr Virus (EBV).
Value and support
Persephoni BioPartners offers hands-on company formation, operational support, capital access, and partnership-building to help innovators translate scientific inventions into viable biotech companies.
Additional public guidance
Q: What is the focus of Persephoni BioPartners? A: Persephoni focuses on early-stage biotech companies with potential therapeutic, diagnostic, or platform-based innovations. Q: Who can apply? A: Innovators and founders with scientific breakthroughs in biotechnology can apply through the website.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Sectors
- Biotech · Healthcare · Diagnostics
- Regions
- United States
Alumni and track record
Alumni context
Notable portfolio companies include: LampRNA Therapeutics: Develops a lysosome-mediated RNA degrader platform to enhance the efficacy of RNA interfering therapies. Telos Therapeutics: A preclinical-stage biotech company creating exosome-based therapies for autoimmunity and oncology. InnoVira: Focuses on developing the first EBV-specific antiviral medication targeting conditions like multiple sclerosis and certain cancers. Monarch Therapeutics: Offers a catalog of modular adaptors for personalized therapy programs.
Programs hosted by Persephoni BioPartners
These Programs have a direct canonical host relationship to this Organization.
Common questions
What to know about Persephoni BioPartners
Upseed classifies Persephoni BioPartners under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.